In response to numerous pathologic stimuli, the myocardium undergoes a
hypertrophic response characterized by increased myocardial cell size
and activation of fetal cardiac genes. We show that cardiac hypertrop
hy is induced by the calcium-dependent phosphatase calcineurin, which
dephosphorylates the transcription factor NF-AT3, enabling it to trans
locate to the nucleus. NF-AT3 interacts with the cardiac zinc finger t
ranscription factor GATA4, resulting in synergistic activation of card
iac transcription. Transgenic mice that express activated forms of cal
cineurin or NF-AT3 in the heart develop cardiac hypertrophy and heart
failure that mimic human heart disease. Pharmacologic inhibition of ca
lcineurin activity blocks hypertrophy in vivo and in vitro. These resu
lts define a novel hypertrophic signaling pathway and suggest pharmaco
logic approaches to prevent cardiac hypertrophy and heart failure.